InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,626.02
(
0.54%
)
US TECH 100
18,986.40
(
0.30%
)
Dow Jones
41,393.78
(
0.72%
)
Brent Oil
71.83
(
0.00%
)
Bitcoin
60,344.27
(
-0.39%
)
Post# of 253120
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gofishmarko

Send PM Follow Ignore
Followers 5
Posts 701
Boards Moderated 0
Alias Born 11/10/2005

gofishmarko

Re: DewDiligence post# 37840

Monday, 11/20/2006 3:18:14 PM

Monday, November 20, 2006 3:18:14 PM

Post# of 253120
re : IDIX

Were any of the patients treated to date with NM283 plus pegifn given the option to continue treatment with SOC ( minus NM283 ) at some point ? If so , IDIX might already have a good feel about the feasiblity of the two stage approach , since the models for predicting SVR are probably pretty reliable once the patient has been switched over to SOC for a couple months.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up